跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,249 条关于
“PPAR alpha”
全部
4,249
临床试验
2,143
药物
1,140
机构
27
资讯
939
去年
Zydus Therapeutics Reports Positive Phase 3 Results for Saroglitazar in Primary Biliary Cholangitis
去年
Lanifibranor Shows Promise in Phase 3 MASH Trial with Improved Liver Health Biomarkers
去年
FDA Grants Accelerated Approval to Ipsen's Iqirvo, First Dual PPAR Agonist for Primary Biliary Cholangitis
去年
Ipsen Secures Dual CHMP Approvals for Rare Liver Disease Treatments Following Regulatory Strategy Shift
上个月
Probiotic-Derived Metabolite 10-HSA Repairs HIV Gut Damage and Boosts ART Response in Preclinical Model
2年前
U.S. FDA Grants Priority Review for Elafibranor, a Potential New Treatment for Primary Biliary Cholangitis
去年
Tempest Therapeutics Seeks Partner for Phase III Liver Cancer Drug Amezalpat Amid Funding Challenges
去年
Tempest Therapeutics Seeks Strategic Partner for Promising Liver Cancer Drug Amezalpat Amid Funding Challenges
10个月前
Real-World Safety Analysis Reveals New Adverse Events Associated with Fenofibric Acid for Hyperlipidemia Treatment
去年
New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis
第 1 页,共 94 页
上一页
下一页